Literature DB >> 28077794

Large-scale genomic deletions mediated by CRISPR/Cas9 system.

Yuning Song1, Liangxue Lai1, Zhanjun Li1.   

Abstract

Entities:  

Keywords:  CRISPR/Cas9 system; large-scale genomic deletions; multiple sgRNAs

Year:  2017        PMID: 28077794      PMCID: PMC5351561          DOI: 10.18632/oncotarget.14543

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


× No keyword cloud information.
Owing to its simplicity of manipulation and high efficiency, the CRISPR/Cas9 technology has already been achieved as a robust genome engineering tool for generating gene mutations, multiple-gene knockout and knock-in in various species. However, tissues and genomic mosaicism have been widely reported in the gentically modified animals generated from zygotes that were co-injected with Cas9 mRNA and single-guide RNA (sgRNA) [1]. Further breeding was therefore necessary to obtain the desired genotype and phenotype. Furthermore, the low efficiency of conventional gene targeting strategies and a lack of mutants have hindered the functional study of gene clusters, long non-coding RNAs (lncRNA) and regulatory sequences. Alternatively, dual sgRNA-directed large gene deletion mediated by CRISPR/Cas9 system is a robust tool for completely eliminate the protein, no mosaic mutations and large deletions of lncRNA genes [2, 3]. Several recent studies have reported the CRISPR/ Cas9 system-induced large genomic deletion, ranged from 23kb to 1Mb, in mouse [4], C. elegans [3], rabbit [5] and human cell lines [6]. However, the major observed is that the larger the size of the deleted fragment, the lower the efficiency. In our study, although we achieved high efficiency (~80%) of deletion with each sgRNA, the efficiency of large fragment deletions was less than 10%. Therefore, improving the efficiency of large fragment deletion is a matter of cardinal significance [5]. Although paired sgRNAs can precisely generate large deletions, the deletion efficiency was doubled (from 16% to 33.3% ) when multiple sgRNAs were used [2]. Previous studies have also reported that combined use of multiple sgRNAs to target an individual gene could improve the efficiency of large fragment deletions [4]. In our study, the efficiency of a 105kb fragment deletion was increased to 17% with four sgRNAs, indicating that multiple sgRNAs can improve the efficiency of large fragment deletion in rabbit [5]. However, higher efficiency of large fragment genomic deletion is not necessarily achieved when more sgRNAs are used. In contrast, increased number of transfected or injected sgRNAs may in fact reduce the efficiency of individual sgRNAs. Therefore, we speculate that no more than four sgRNA are required for the high efficiency of CRISPR/Cas9 directed large fragment deletion. It is well-known that the mechanism of CRISPR/ Cas9 mediated gene mutation is DNA double-strand breaks (DSB), then followed by induced Homologous Recombination (HR) and Non-Homologous End-Joining (NHEJ). NHEJ events are more predominant than HR and also correlate with the observed frequency of genomic deletions or inversions in eukaryotic genomes [7]. Thus, we hypothesize that the reason for the low efficiency of CRISPR/Cas9 directed large fragment deletions is due to the desired DSBs being repaired during NHEJ events. Reasonable inhibition of NHEJ can increase the co-action time of multiple sgRNAs. Previously study have shown that DNA-dependent protein kinase catalytic subunit (DNA-PKcs), Ku70/80, Ligase IV and XRCC4 play a key roles on NHEJ [7]. Specifics inhibitors have been designed to target differentactors of the DSB repaire pathway. Therefore, it is necessary to investigat the possibility of using small molecule inhibitors (NU7441 and KU- 0060648) that target DNA-PKcs to restrain the rates of NHEJ repair events, and as to improve the efficiency of large-scale genomic deletions by the CRISPR/Cas9 system. Taken together, we believe that the mechanism of large-scale genomic deletion mediated by CRISPR/ Cas9 system warrants further exploration. Furthermore, the CRISPR/Cas9 system in combination with multiple sgRNAs provides a powerful platform for easy generation of large-scale deletions in the genome of an organism.
  7 in total

Review 1.  Genetic manipulation of genomes with rare-cutting endonucleases.

Authors:  M Jasin
Journal:  Trends Genet       Date:  1996-06       Impact factor: 11.639

2.  Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting.

Authors:  Jiankui Zhou; Jianying Wang; Bin Shen; Li Chen; Yang Su; Jing Yang; Wensheng Zhang; Xuemei Tian; Xingxu Huang
Journal:  FEBS J       Date:  2014-02-26       Impact factor: 5.542

3.  Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer.

Authors:  Xiaoqing Zhou; Jige Xin; Nana Fan; Qingjian Zou; Jiao Huang; Zhen Ouyang; Yu Zhao; Bentian Zhao; Zhaoming Liu; Sisi Lai; Xiaoling Yi; Lin Guo; Miguel A Esteban; Yangzhi Zeng; Huaqiang Yang; Liangxue Lai
Journal:  Cell Mol Life Sci       Date:  2014-10-02       Impact factor: 9.261

4.  Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9.

Authors:  Jinxiong Han; Jun Zhang; Li Chen; Bin Shen; Jiankui Zhou; Bian Hu; Yinan Du; Peri H Tate; Xingxu Huang; Wensheng Zhang
Journal:  RNA Biol       Date:  2014-08-19       Impact factor: 4.652

5.  Efficient dual sgRNA-directed large gene deletion in rabbit with CRISPR/Cas9 system.

Authors:  Yuning Song; Lin Yuan; Yong Wang; Mao Chen; Jichao Deng; Qingyan Lv; Tingting Sui; Zhanjun Li; Liangxue Lai
Journal:  Cell Mol Life Sci       Date:  2016-01-27       Impact factor: 9.261

6.  Dual sgRNA-directed gene knockout using CRISPR/Cas9 technology in Caenorhabditis elegans.

Authors:  Xiangyang Chen; Fei Xu; Chengming Zhu; Jiaojiao Ji; Xufei Zhou; Xuezhu Feng; Shouhong Guang
Journal:  Sci Rep       Date:  2014-12-22       Impact factor: 4.379

7.  Efficient and versatile CRISPR engineering of human neurons in culture to model neurological disorders.

Authors:  Ruth R Shah; Justyna Cholewa-Waclaw; Faith C J Davies; Katie M Paton; Ronan Chaligne; Edith Heard; Catherine M Abbott; Adrian P Bird
Journal:  Wellcome Open Res       Date:  2016-11-15
  7 in total
  5 in total

1.  Exploring the Potential of Symmetric Exon Deletion to Treat Non-Ischemic Dilated Cardiomyopathy by Removing Frameshift Mutations in TTN.

Authors:  Ignacio Rodriguez-Polo; Rüdiger Behr
Journal:  Genes (Basel)       Date:  2022-06-19       Impact factor: 4.141

2.  Elucidation of CRISPR-Cas9 application in novel cellular immunotherapy.

Authors:  Sameer Quazi
Journal:  Mol Biol Rep       Date:  2022-02-05       Impact factor: 2.742

3.  Developing oncolytic Herpes simplex virus type 1 through UL39 knockout by CRISPR-Cas9.

Authors:  Saeedeh Ebrahimi; Manoochehr Makvandi; Samaneh Abbasi; Kayhan Azadmanesh; Ali Teimoori
Journal:  Iran J Basic Med Sci       Date:  2020-07       Impact factor: 2.699

Review 4.  Applications of and considerations for using CRISPR-Cas9-mediated gene conversion systems in rodents.

Authors:  Hannah A Grunwald; Alexander J Weitzel; Kimberly L Cooper
Journal:  Nat Protoc       Date:  2021-12-23       Impact factor: 13.491

Review 5.  Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome Editing.

Authors:  Jie Liu; Guangyu Zhou; Li Zhang; Qi Zhao
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.